
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About
American Shared Hospital Service (AMS)


- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)

(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: AMS (1-star) is a SELL. SELL since 3 days. Simulated Profits (-19.31%). Updated daily EoD!
Analysis of Past Performance
Type Stock | Historic Profit -43.44% | Avg. Invested days 24 | Today’s Advisory SELL |
Upturn Star Rating ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() | ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 15.75M USD | Price to earnings Ratio 11.63 | 1Y Target Price 4.85 |
Price to earnings Ratio 11.63 | 1Y Target Price 4.85 | ||
Volume (30-day avg) - | Beta 0.29 | 52 Weeks Range 2.30 - 4.60 | Updated Date 06/29/2025 |
52 Weeks Range 2.30 - 4.60 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.21 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 4.93% | Operating Margin (TTM) -14.17% |
Management Effectiveness
Return on Assets (TTM) 0.71% | Return on Equity (TTM) 2% |
Valuation
Trailing PE 11.63 | Forward PE 7.58 | Enterprise Value 32553125 | Price to Sales(TTM) 0.54 |
Enterprise Value 32553125 | Price to Sales(TTM) 0.54 | ||
Enterprise Value to Revenue 1.11 | Enterprise Value to EBITDA 4.15 | Shares Outstanding 6450000 | Shares Floating 3419790 |
Shares Outstanding 6450000 | Shares Floating 3419790 | ||
Percent Insiders 49.7 | Percent Institutions 13.91 |
Upturn AI SWOT
American Shared Hospital Service
Company Overview
History and Background
American Shared Hospital Service (AMS: NYSE) was founded in 1980. Initially focused on mobile diagnostic imaging, it transitioned to providing stereotactic radiosurgery and advanced radiation therapy equipment and services to hospitals on a shared-service basis. It was founded by Thomas M. Crowley
Core Business Areas
- Stereotactic Radiosurgery (SRS) and Radiation Therapy: Provides Gamma Knife and other advanced radiation therapy technologies to hospitals under long-term agreements.
- Equipment Leasing: Leases medical equipment to hospitals and clinics.
Leadership and Structure
Ernest A. Bates, M.D. is the Chairman of the Board. Ray Stachowiak is the Chief Executive Officer. The company has a board of directors and a management team overseeing operations and strategy.
Top Products and Market Share
Key Offerings
- Gamma Knife: Provides Gamma Knife radiosurgery services. Gamma Knife is the gold standard for treating brain tumors and other neurological conditions. Market share data isn't publicly available, but AMS is a significant player. Competitors include Elekta and Varian Medical Systems (now Siemens Healthineers).
- LINAC Systems (Linear Accelerator): Provides LINAC systems (radiation therapy). Competitors include Elekta and Varian Medical Systems (now Siemens Healthineers).
- MR-Linac: Provides MR-Linac radiation therapy systems, enabling real-time imaging during treatment. No official market share data exists. Competitors include Elekta Unity MR-Linac.
Market Dynamics
Industry Overview
The medical equipment leasing and shared-service market is driven by technological advancements, aging populations, and the increasing cost of healthcare. There is a growing demand for advanced cancer treatment options.
Positioning
American Shared Hospital Service occupies a niche position, providing cost-effective access to advanced medical technology for hospitals. Its competitive advantage lies in its shared-service model, which reduces capital expenditure for hospitals.
Total Addressable Market (TAM)
The global medical equipment rental and leasing market is projected to reach hundreds of billions USD. AMS targets a specific segment focused on advanced radiation therapy and stereotactic radiosurgery and has the potential to further expand the size of hospitals and customers in general.
Upturn SWOT Analysis
Strengths
- Specialized expertise in SRS and radiation therapy
- Long-term contracts with hospitals
- Shared-service model reduces capital expenditure for hospitals
- Strong relationships with equipment manufacturers
Weaknesses
- Small market capitalization
- High dependence on a few key clients
- Exposure to regulatory changes in healthcare
- Limited geographic diversification
Opportunities
- Expansion into new geographic markets
- Adoption of new medical technologies
- Increasing demand for advanced cancer treatment
- Partnerships with larger healthcare providers
Threats
- Competition from larger medical equipment companies
- Technological obsolescence
- Changes in reimbursement policies
- Economic downturn affecting hospital budgets
Competitors and Market Share
Key Competitors
- Siemens Healthineers (SHI)
- Elekta (EKTA-B.ST)
- Accuray (ARAY)
Competitive Landscape
American Shared Hospital Service competes with larger companies. Its advantage lies in its specialization and shared-service model, but is disadvantaged by small market capitalization.
Growth Trajectory and Initiatives
Historical Growth: American Shared Hospital Service has experienced growth driven by demand for its services. The current trend is positive with revenue and net income growth.
Future Projections: Analyst estimates vary. Focus should be placed on trends in cancer treatment, shared service models and equipment leasing.
Recent Initiatives: Recent initiatives include expanding service offerings and pursuing new partnerships.
Summary
American Shared Hospital Service occupies a unique niche in the medical equipment and service market, but it is small in size. It benefits from specialized expertise and long-term agreements, which is a strength. Growth and long term profitability hinges on the company's success in expanding its customer base, keeping a keen eye on competition and technological obsolescence.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC filings (10-K, 10-Q)
- Company website
- Market research reports
- Analyst reports
- Press Releases
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market share data is approximate and based on available information. Investment decisions should be based on thorough research and consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About American Shared Hospital Service
Exchange NYSE MKT | Headquaters San Francisco, CA, United States | ||
IPO Launch date 1984-09-07 | CEO - | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 81 | Website https://ashs.com |
Full time employees 81 | Website https://ashs.com |
American Shared Hospital Services provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services. It operates in two segments, Leasing and Retail. The company leases nine Gamma Knife systems and one proton beam radiation therapy (PBRT) system; and provides planning, installation, reimbursement, and marketing support services. It also owns and operates two single-unit Gamma Knife facilities that provides radiosurgery services directly to the patient. The company markets its solutions to cancer treatment centers, health systems, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.